{"id":42,"date":"2024-05-09T09:11:50","date_gmt":"2024-05-09T08:11:50","guid":{"rendered":"https:\/\/blogs.imperial.ac.uk\/csep-and-telecoms\/?p=42"},"modified":"2026-03-31T10:28:06","modified_gmt":"2026-03-31T09:28:06","slug":"unleashing-the-potential-of-uk-medtech","status":"publish","type":"post","link":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/","title":{"rendered":"Unleashing the Potential of UK MedTech"},"content":{"rendered":"

Authors:<\/strong> Professor James Moore Jr, Yunus Kutlu<\/p>\n

We have no shortage of innovative ideas or talented people in MedTech in this country. But in my eleven years as a professor of medical device design at Imperial, I\u2019ve seen countless good ideas go to waste. At the Centre for Sectoral Economic Performance, we are investigating why this is and what industry, government and academia can do to change it.<\/p>\n

<\/p>\n

MedTech\u2019s outsize contribution to the UK economy <\/strong><\/p>\n

MedTech is any technology that a clinician might use to improve or to save a patient\u2019s life \u2013 from pacemakers to prosthetic limbs, MRI scans to plasters. The UK sector, which is mostly SMEs, employs 163,00 people and has an annual turnover of \u00a336 billion.[1]<\/sup><\/a><\/p>\n

Despite being half the size of Biopharmaceuticals in terms of jobs, MedTech contributes \u00a313.5 billion to the UK economy annually, about the same as Biopharma\u2019s \u00a315 billion. Its annual growth rate between 2016 and 2020 was 19% \u2013 far higher than Biopharma\u2019s 3%.[2]<\/sup><\/a><\/p>\n

But the MedTech sector\u2019s remarkable vitality is in spite \u2013 not because \u2013 of government policy. Regulatory uncertainty, scarce funding, and ineffective NHS procurement processes make it extremely difficult for MedTech inventions to develop into viable businesses.<\/p>\n

The Peezy: a breakthrough device now withdrawn from the UK<\/strong><\/p>\n

Forte Medical\u2019s Peezy device, invented in the UK but now only available in the US, is a dispiritingly typical example.[3]<\/sup><\/a><\/p>\n

NHS GP Dr Vincent Forte invented the Peezy and founded Forte Medical with his sister Giovanna in 2002. The Peezy is a cheap-to-produce device which makes midstream urine samples easier to collect. Forte Medical made a prototype, secured a patent, then ran real-world trials which showed that the Peezy radically reduces the risk of contamination, and therefore the unnecessary prescription of antibiotics. The potential benefits to the NHS were enormous.<\/p>\n

Yet twenty-two years since the invention of the Peezy, NHS doctors are still sending female patients \u2013 sometimes heavily pregnant, sometimes elderly and frail \u2013 to surgery toilets with tiny sample vials and near impossible-to-follow instructions. Due to siloed budgets, resistance to change and lack of incentives for adoption, Forte Medical has withdrawn completely from the UK NHS market.<\/p>\n

I see similar stories time and again. In just over a decade at Imperial, I have helped ten spinout companies form out of my department. One has been highly successful at securing investment. Two or three are just about managing. The rest have foundered. This doesn\u2019t inspire our students to pursue biomedical engineering and develop MedTech devices.<\/p>\n

The policy solution: certainty, funding, and procurement <\/strong><\/p>\n

But it\u2019s a story we can change. With focused industry\/government interventions, the UK can unleash the full potential of UK MedTech.<\/p>\n

First and most pressingly, MedTech companies need regulatory certainty<\/strong>.<\/p>\n

Because the UK represents only 3% of the global market, UK MedTech companies prioritise exports. Post-Brexit, the UK adopted its own regulatory framework, based on the EU’s Medical Device Directive (MDD) and overseen by the MHRA. But the EU’s ongoing transition to the Medical Device Regulation (MDR) means that 70% of UK-made devices will soon be noncompliant. It may also lead to some life-saving technologies being unavailable to NHS patients.<\/p>\n

The MHRA should align regulations with those of the MDR and the American Food and Drug Administration (FDA). Outside those frameworks, there are opportunities to make the UK a more desirable destination for clinical trials of cutting-edge technologies. The Treasury should increase MHRA\u2019s budget to that end.<\/p>\n

Second, MedTech companies need better access to funding<\/strong>.<\/p>\n

While the MedTech sector produces more university spinouts than Biopharma, the underlying research funding base for MedTech is only one fifteenth the size of the funding available to Biopharma. Sources of grant funding for MedTech SMEs are limited to Innovate UK and the National Institute for Health and Care Research (NIHR), where only about half of the applications determined to be viable actually get funded. Private investment is scarce and concentrated towards established companies.<\/p>\n

So the Department for Health and Social Care (DHSC) and UK Research and Innovation (UKRI) should increase funding for NIHR and Innovate UK to a sufficient level that all viable projects can receive funding.<\/p>\n

Finally, MedTech companies need the NHS to overhaul its innovation and procurement culture.<\/strong> The NHS\u2019s ineffective procurement processes make it difficult for MedTech firms to access the UK market. It also prevents UK patients from reaping the benefits of the NHS\u2019s position as an ideal testing ground for new technologies.<\/p>\n

Universities must push for tailored support for MedTech spinouts<\/strong><\/p>\n

The government must do more to support the UK’s special position as a market primed for MedTech innovation. There are more MedTech spinouts than any other type of university spinout.<\/p>\n

University innovation and entrepreneurship programmes should also provide tailored support for MedTech spinouts. Imperial\u2019s new venture fund, Science Capital, will provide Imperial\u2019s entrepreneurs access to capital and proof-of-concept funding to realise the full potential of their businesses.<\/p>\n

MedTech is a key research area for both the White City Deep Tech Campus and the Centre for Sectoral Economic Performance, who sponsored our analysis of the UK MedTech sector.<\/p>\n

The detailed policy recommendations in the resulting report should form a central input to a government wishing to develop a growth strategy for the country – they show how these industries could increase the UK\u2019s global competitiveness and value added per capita. If the recommendations are implemented, there\u2019s almost no limit to the good that MedTech can do \u2013 not only for the UK economy but for patients all around the world.[4]<\/sup><\/a><\/p>\n

Professor James Moore<\/em><\/strong> is the Bagrit Chair in Medical Device Design at the Department of Bioengineering, and co-author of \u2018Sectoral Systems of Innovation and the UK\u2019s Competitiveness: The UK MedTech Sector\u2019 published by the Centre for Sectoral Economic Performance. He does research on the lymphatic system, initiated two degree programmes in MedTech entrepreneurship and has co-founded five MedTech startup companies.<\/em><\/p>\n

The Centre for Sectoral Economic Performance<\/em><\/strong> at Imperial College London investigates how to improve the competitiveness of the UK economy and drive economic growth. It is a joint initiative between Imperial\u2019s Faculty of Engineering and the Imperial College Business School \u2013bringing together the UK\u2019s top engineers, scientists and economists with the UK\u2019s science and technology industries to co-design globally competitive strategies for major global challenges: like net zero, economic competition and technological disruptions.<\/em><\/p>\n

[1]<\/sup><\/a> 348-IMP-Public-Affairs-3-reports_Medtech_AW_DIGITAL_SINGLES_Sept23.pdf (imperial.ac.uk)<\/a>, p. 17.<\/p>\n

[2]<\/sup><\/a> 348-IMP-Public-Affairs-3-reports_Medtech_AW_DIGITAL_SINGLES_Sept23.pdf (imperial.ac.uk)<\/a>, p. 9.<\/p>\n

[3]<\/sup><\/a> Peezy Midstream UK \u2013 Forte Medical (forte-medical.co.uk)<\/a><\/p>\n

[4]<\/sup><\/a> 348-IMP-Public-Affairs-3-reports_Medtech_AW_DIGITAL_SINGLES_Sept23.pdf (imperial.ac.uk)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Authors: Professor James Moore Jr, Yunus Kutlu We have no shortage of innovative ideas or talented people in MedTech in this country. But in my eleven years as a professor of medical device design at Imperial, I\u2019ve seen countless good ideas go to waste. At the Centre for Sectoral Economic Performance, we are investigating why […]<\/p>\n","protected":false},"author":1805,"featured_media":45,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-42","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-technology"],"yoast_head":"\nUnleashing the Potential of UK MedTech - Centre for Sectoral Economic Performance Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unleashing the Potential of UK MedTech - Centre for Sectoral Economic Performance Blog\" \/>\n<meta property=\"og:description\" content=\"Authors: Professor James Moore Jr, Yunus Kutlu We have no shortage of innovative ideas or talented people in MedTech in this country. But in my eleven years as a professor of medical device design at Imperial, I\u2019ve seen countless good ideas go to waste. At the Centre for Sectoral Economic Performance, we are investigating why […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/\" \/>\n<meta property=\"og:site_name\" content=\"Centre for Sectoral Economic Performance Blog\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-09T08:11:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-31T09:28:06+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/blogs.imperial.ac.uk\/csep\/files\/2024\/05\/23324.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1079\" \/>\n\t<meta property=\"og:image:height\" content=\"305\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"The Centre for Sectoral Economic Performance\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"The Centre for Sectoral Economic Performance\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/\"},\"author\":{\"name\":\"The Centre for Sectoral Economic Performance\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/#\\\/schema\\\/person\\\/01f29d7491672a55d9b4c2a1bd526683\"},\"headline\":\"Unleashing the Potential of UK MedTech\",\"datePublished\":\"2024-05-09T08:11:50+00:00\",\"dateModified\":\"2026-03-31T09:28:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/\"},\"wordCount\":1102,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/files\\\/2024\\\/05\\\/23324.jpg\",\"articleSection\":[\"Medical Technology\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/\",\"name\":\"Unleashing the Potential of UK MedTech - Centre for Sectoral Economic Performance Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/files\\\/2024\\\/05\\\/23324.jpg\",\"datePublished\":\"2024-05-09T08:11:50+00:00\",\"dateModified\":\"2026-03-31T09:28:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/#\\\/schema\\\/person\\\/01f29d7491672a55d9b4c2a1bd526683\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/files\\\/2024\\\/05\\\/23324.jpg\",\"contentUrl\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/files\\\/2024\\\/05\\\/23324.jpg\",\"width\":1079,\"height\":305},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/2024\\\/05\\\/09\\\/unleashing-the-potential-of-uk-medtech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Unleashing the Potential of UK MedTech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/#website\",\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/\",\"name\":\"Centre for Sectoral Economic Performance Blog\",\"description\":\"Insights and updates from the Centre for Sectoral Economic Performance\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/#\\\/schema\\\/person\\\/01f29d7491672a55d9b4c2a1bd526683\",\"name\":\"The Centre for Sectoral Economic Performance\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfe6dae32e3fd07a32e912d209d8bcc4317cde17fc8064c86699fded690feb28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfe6dae32e3fd07a32e912d209d8bcc4317cde17fc8064c86699fded690feb28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfe6dae32e3fd07a32e912d209d8bcc4317cde17fc8064c86699fded690feb28?s=96&d=mm&r=g\",\"caption\":\"The Centre for Sectoral Economic Performance\"},\"url\":\"https:\\\/\\\/blogs.imperial.ac.uk\\\/csep\\\/author\\\/gellis\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Unleashing the Potential of UK MedTech - Centre for Sectoral Economic Performance Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/","og_locale":"en_GB","og_type":"article","og_title":"Unleashing the Potential of UK MedTech - Centre for Sectoral Economic Performance Blog","og_description":"Authors: Professor James Moore Jr, Yunus Kutlu We have no shortage of innovative ideas or talented people in MedTech in this country. But in my eleven years as a professor of medical device design at Imperial, I\u2019ve seen countless good ideas go to waste. At the Centre for Sectoral Economic Performance, we are investigating why […]","og_url":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/","og_site_name":"Centre for Sectoral Economic Performance Blog","article_published_time":"2024-05-09T08:11:50+00:00","article_modified_time":"2026-03-31T09:28:06+00:00","og_image":[{"width":1079,"height":305,"url":"http:\/\/blogs.imperial.ac.uk\/csep\/files\/2024\/05\/23324.jpg","type":"image\/jpeg"}],"author":"The Centre for Sectoral Economic Performance","twitter_card":"summary_large_image","twitter_misc":{"Written by":"The Centre for Sectoral Economic Performance","Estimated reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#article","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/"},"author":{"name":"The Centre for Sectoral Economic Performance","@id":"https:\/\/blogs.imperial.ac.uk\/csep\/#\/schema\/person\/01f29d7491672a55d9b4c2a1bd526683"},"headline":"Unleashing the Potential of UK MedTech","datePublished":"2024-05-09T08:11:50+00:00","dateModified":"2026-03-31T09:28:06+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/"},"wordCount":1102,"commentCount":0,"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/csep\/files\/2024\/05\/23324.jpg","articleSection":["Medical Technology"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/","url":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/","name":"Unleashing the Potential of UK MedTech - Centre for Sectoral Economic Performance Blog","isPartOf":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#primaryimage"},"image":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.imperial.ac.uk\/csep\/files\/2024\/05\/23324.jpg","datePublished":"2024-05-09T08:11:50+00:00","dateModified":"2026-03-31T09:28:06+00:00","author":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/#\/schema\/person\/01f29d7491672a55d9b4c2a1bd526683"},"breadcrumb":{"@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#primaryimage","url":"https:\/\/blogs.imperial.ac.uk\/csep\/files\/2024\/05\/23324.jpg","contentUrl":"https:\/\/blogs.imperial.ac.uk\/csep\/files\/2024\/05\/23324.jpg","width":1079,"height":305},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.imperial.ac.uk\/csep\/2024\/05\/09\/unleashing-the-potential-of-uk-medtech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.imperial.ac.uk\/csep\/"},{"@type":"ListItem","position":2,"name":"Unleashing the Potential of UK MedTech"}]},{"@type":"WebSite","@id":"https:\/\/blogs.imperial.ac.uk\/csep\/#website","url":"https:\/\/blogs.imperial.ac.uk\/csep\/","name":"Centre for Sectoral Economic Performance Blog","description":"Insights and updates from the Centre for Sectoral Economic Performance","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.imperial.ac.uk\/csep\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/blogs.imperial.ac.uk\/csep\/#\/schema\/person\/01f29d7491672a55d9b4c2a1bd526683","name":"The Centre for Sectoral Economic Performance","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/bfe6dae32e3fd07a32e912d209d8bcc4317cde17fc8064c86699fded690feb28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfe6dae32e3fd07a32e912d209d8bcc4317cde17fc8064c86699fded690feb28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfe6dae32e3fd07a32e912d209d8bcc4317cde17fc8064c86699fded690feb28?s=96&d=mm&r=g","caption":"The Centre for Sectoral Economic Performance"},"url":"https:\/\/blogs.imperial.ac.uk\/csep\/author\/gellis\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/posts\/42","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/users\/1805"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/comments?post=42"}],"version-history":[{"count":4,"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/posts\/42\/revisions"}],"predecessor-version":[{"id":332,"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/posts\/42\/revisions\/332"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/media\/45"}],"wp:attachment":[{"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/media?parent=42"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/categories?post=42"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.imperial.ac.uk\/csep\/wp-json\/wp\/v2\/tags?post=42"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}